Selenium level and cognitive function in rural elderly Chinese

American Journal of Epidemiology

Volumn 165, Issue 8, 2007, Pages 955-965

  Gao, Sujuan ^a   Jin, Yinlong ^b   Hall, Kathleen S ^a   Liang, Chaoke ^b   Unverzagt, Frederick W ^a   Ji, Rongdi ^b   Murrell, Jill R ^a   Cao, Jingxiang ^b   Shen, Jianzhao ^a   Ma, Feng ^b   Matesan, Janetta ^a   Ying, Bo ^b   Cheng, Yibin ^b   Bian, Jianchao ^c   Li, Ping ^d   Hendrie, Hugh C ^a,e  

^a INDIANA UNIVERSITY   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Shandong Institute for Prevention and Treatment of Endemic Disease in China   (China)

^d Sichuan Provincial Center for Disease Control and Prevention in China   (China)

^e REGENSTRIEF INSTITUTE   (United States)

Author keywords

Aged; Asian continental ancestry group; Cognition; Selenium

Indexed keywords

SELENIUM;

ANTIOXIDANT; COGNITION; DOSE-RESPONSE RELATIONSHIP; ELDERLY POPULATION; ENZYME ACTIVITY; FREE RADICAL; NERVOUS SYSTEM DISORDER; RURAL AREA; SELENIUM;

AGED; AGING; ALZHEIMER DISEASE; ANALYSIS OF COVARIANCE; ARTICLE; BIRTH; CHINA; CHINESE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; FEMALE; GEOGRAPHY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEMORY; NAIL; RATING SCALE; RURAL AREA; SAMPLE; SCREENING TEST;

AGED; CHINA; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NAILS; SELENIUM;

ASIA; CHINA; EURASIA; FAR EAST;

ANIMALIA;

EID: 34047207603     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwk073     Document Type: Article

References (71)

1. Flatt A, Pearce N, Thomson CD, et al. Reduced selenium in asthmatic subjects in New Zealand. Thorax 1990;45:95-9.
2. Florence TM. The role of free radicals in disease. Aust N Z J Ophthalmol 1995;23:3-7.
3. Corrigan FM, Reynolds GP, Ward NI. Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals 1993;6:149-54.
4. Markesbery WR, Ehmann WD. Brain trace elements in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's disease. New York, NY: Raven Press, 1994:353-67.
5. Mattielo G, Gerotto M, Favarato M, et al. Plasma microelemental analysis from Alzheimer's and multi-infarctual dementia patients. In: Corain B, ed. Alzheimer's disease: advances in clinical and basic research. Chichester, United Kingdom: John Wiley, 1993:267-72.
6. Ceballos-Picot I, Merad-Boudia M, Nicole A, et al. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type - place of the extracellular glutathione peroxidase. Free Radic Biol Med 1996;20:579-87.
7. Meseguer I, Molina JA, Jimenez-Jimenez FJ, et al. Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease. J Neural Transm 1999;106:309-15.
8. Perkins AJ, Hendrie HC, Callahan CM, et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999;150:37-44.
9. Berr C, Balansard B, Arnaud J, et al. Cognitive decline is associated with systemic oxidative stress: the EVA Study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 2000;48:1285-91.
10. Mendelsohn AB, Belle SH, Stoehr GP, et al. Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey. Am J Epidemiol 1998;148:38-44.
11. Gray SL, Hanlon JT, Landerman LR, et al. Is antioxidant use protective of cognitive function in the community-dwelling elderly? Am J Geriatr Pharmacother 2003;1:3-10.
12. Snowdon DA, Kemper SJ, Mortimer JA, et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996;275:528-32.
13. Graves AB, Mortimer JA, Larson EB, et al. Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimer's disease. Br J Psychiatry 1996;169:86-92.
14. Abbott RD, White LR, Ross GW, et al. Height as a marker of childhood development and late-life cognitive function: the Honolulu-Asia Aging Study. Pediatrics 1998;102:602-9.
15. Hall KS, Gao S, Unverzagt FW, et al. Low education and childhood rural residence: risk for Alzheimer's disease in African Americans. Neurology 2000;54:95-9.
16. Moceri VM, Kukull WA, Emanuel I, et al. Early-life risk factors and the development of Alzheimer's disease. Neurology 2000;54:415-20.
17. Wilson RS, Scherr PA, Hoganson G, et al. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology 2005;25:8-14.
18. Borenstein AR, Copenhaver CI, Mortimer JA. Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 2006;20:63-72.
19. World Health Organization. Selenium. Environmental health criteria 58: a report of the International Programme on Chemical Safety. Geneva, Switzerland: World Health Organization, 1987.
20. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65.
21. Isaacs B, Akhtar AJ. The set test: a rapid test of mental function in old people. Age Ageing 1972;1:222-6.
22. Hall KS, Ogunniyi AO, Hendrie HC, et al. A cross-cultural community based study of dementias: methods and performance of the survey instrument: Indianapolis, U.S.A. and Ibadan, Nigeria. Int J Methods Psychiatr Res 1996;6:129-42.
23. Hall KS, Gao S, Emsley CL, et al. Community screening interview for dementia (CSI 'D'); performance in five disparate study sites. Int J Geriatr Psychiatry 2000;15:521-31.
24. Emsley CL, Gao S, Li Y, et al. Trace element levels in drinking water and cognitive function among elderly Chinese. Am J Epidemiol 2000;151:913-20.
25. Yamamoto K, Evans JD, Johnson KE, et al. Clinical utility of IU Token Test in the diagnosis of dementia. Presented at the Thirty-First Annual International Neuropsychological Society Conference, Honolulu, Hawaii, February 5-8, 2003.
26. Prince M, Acosta D, Chiu H, et al. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003;361:909-17.
27. Li M, Cao J, Sun S. Microfluorometric determination of trace amounts of selenium in blood, hair and milk powder. (In Chinese). Chin J Public Health 1991;10:306-8.
28. Chen J, Campbell TC, Li J, et al. Diet, lifestyle and mortality in China. Oxford, United Kingdom: Oxford University Press, 1990.
29. Cao J, Chen S, Sun S. A comparison of methods for estimating large population dietary fluoride intake in coal burning high fluoride communities. (In Chinese). Wei Sheng Yan Jiu 1993;22:52-4.
30. Zhai F, Popkin BM, Ma L, et al. Evaluation of the 24-hour individual dietary recall method in China. (In Chinese). Wei Sheng Yan Jiu 1996;25:51-6.
31. Cao J, Yan B, Zhang S, et al. Relations between heavy exposure of selenium-fluoride and human health. (In Chinese). Wei Sheng Yan Jiu 1996;25:287-90.
32. He L. Summary for method and application of food frequency survey. (In Chinese). J Foreign Med Sci Hyg Sect 2003;30:368-71.
33. Yang M, Hendrie HC, Hall KS, et al. Improved procedure for eluting DNA from dried blood spots. Clin Chem 1996;42:1115-16.
34. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
35. Stampfer MJ, Kang JH, Chen J, et al. Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med 2005;352:245-53.
36. Wilson RS, Li Y, Aggarwal NT, et al. Education and the course of cognitive decline in Alzheimer disease. Neurology 2004;63:1198-202.
37. Soderlund H, Nyberg L, Nilsson LG. Cerebral atrophy as predictor of cognitive function in old, community-dwelling individuals. Acta Neurol Scand 2004;109:398-406.
38. Fleischman DA, Wilson RS, Bienias JL, et al. Parkinsonian signs and cognitive function in old age. J Int Neuropsychol Soc 2005;11:591-7.
39. Booth JE, Schinka JA, Brown LM, et al. Five-factor personality dimensions, mood states, and cognitive performance in older adults. J Clin Exp Neuropsychol 2006;28:676-83.
40. Berr C, Richard MJ, Roussel AM, et al. Systemic oxidative stress and cognitive performance in the population-based EVA Study. Etude du Vieillissement Arteriel. Free Radic Biol Med 1998;24:1202-8.
41. Unverzagt FW, Morgan OS, Thesiger CH, et al. Clinical utility of CERAD neuropsychological battery in elderly Jamaicans. J Int Neuropsychol Soc 1999;5:255-9.
42. Unverzagt FW, Gao S, Baiyewu O, et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655-62.
43. Mayne ST, Wright ME, Cartmel B. Assessment of antioxidant nutrient intake and status for epidemiologic research. J Nutr 2004;134(suppl):3199S-200S.
44. Thomson CD, Robinson MF. Urinary and faecal excretion and absorption of a large supplement of selenium: superiority of selenate over selenite. Am J Clin Nutr 1986;44:659-63.
45. 75Se] in young women. Br J Nutr 1974;32:47-57.
46. Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000.
47. Toxicological profile for selenium. Atlanta, GA: Agency for Toxic Substances and Disease Registry, US Public Health Service, 1989.
48. Morris JS, Stampfer MJ, Willett W. Dietary selenium in humans: toenails as an indicator. Biol Trace Elem Res 1983;5:529-37.
49. Krogh V, Pala V, Vinceti M, et al. Toenail selenium as biomarker: reproducibility over a one-year period and factors influencing reproducibility. J Trace Elem Med Biol 2003;17(suppl 1):31-6.
50. Hunter DJ, Morris JS, Chute CG, et al. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990;132:114-22.
51. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:493-7.
52. Longnecker MP, Stram DO, Taylor PR, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996;7:384-90.
53. Yang G, Zhou R, Yin S, et al. Studies of safe maximal daily dietary selenium intake in a seleniferous area in China. I. Selenium intake and tissue selenium levels of the inhabitants. J Trace Elem Electrolytes Health Dis 1989;3:77-87.
54. Moskovitz J, Stadtman ER. Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues. Proc Natl Acad Sci U S A 2003;100:7486-90.
55. Ruan H, Tang XD, Chen ML, et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci U S A 2002;99:2748-53.
56. Karunasinghe N, Ryan J, Tuckey J, et al. DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13:391-7.
57. Joseph KS, Kramer MS. Review of the evidence on fetal and early childhood antecedents of adult chronic disease. Epidemiol Rev 1996;18:158-74.
58. Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol 1991;82:239-59.
59. Schweizer U, Schomburg L, Savaskan NE. The neurobiology of selenium: lessons from transgenic mice. J Nutr 2004;134:707-10.
60. Buckman TD, Sutphin MS, Eckhert CD. A comparison of the effects of dietary selenium on selenoprotein expression in rat brain and liver. Biochim Biophys Acta 1993;1163:176-84.
61. Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev 2004;13:771-8.
62. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-49.
63. Mak YT, Chiu H, Woo J, et al. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-9.
64. Kao JT, Tsai KS, Chang CJ, et al. The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995;114:55-9.
65. Katzman R, Zhang MY, Chen PJ, et al. Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology 1997;49:779-85.
66. Mayeux R, Small SA, Tang M, et al. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiol Aging 2001;22:683-9.
67. Levy JA, Bergeson J, Putnam K, et al. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease. J Int Neuropsychol Soc 2004;10:362-70.
68. Buchman AS, Wilson RS, Bienias JL, et al. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892-7.
69. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2005;62:55-60.
70. Gustafson D, Rothenberg E, Blennow K, et al. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003;163:1524-8.
71. Cronin-Stubbs D, Beckett LA, Scherr PA, et al. Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ 1997;314:178-9.